Molecular Pharmacology and Physiology
USF Health � College of Medicine
Login here to update your profile  
My Profile

Paul Sanberg , PHD

Primary Department: CENTER OF EXCELLENCE FOR AGING & BRAIN REPAIR

Distinguished Professor
COLLEGE OF MEDICINE MOLECULAR PHARMACOLOGY & PHYSIOLOGY

Distinguished Professor
COLLEGE OF MEDICINE NEUROLOGY

Distinguished Professor
COLLEGE OF MEDICINE PSYCHIATRY AND BEHAVIORAL NEUROSCIENCES

Professor
COLLEGE OF MEDICINE PATHOLOGY & CELL BIOLOGY

Sr VP USF & Dist Professor
CENTER OF EXCELLENCE FOR AGING & BRAIN REPAIR
profile Image
Contacts
Email: psanberg@health.usf.edu
Phone: (813) 974-4586 ext. 4586
Office: MDT, 1599
 
Education
  • PHD, Biological Sciences, Australian National University , Australia - 1981.
    		•
     
     


    Selected Publications
  • Zhu, Y.Bickford, PC.Sanberg, P.Giunta, B.Tan, J. Blueberry opposes beta-amyloid peptide-induced microglial activation via inhibition of p44/42 mitogen-activation protein kinase. Rejuvenation research. 11(5): 891-901, 2008.
  • Jiang, L.Newman, M.Saporta, S.Chen, N.Sanberg, C.Sanberg, PR.Willing, AE. MIP-1alpha and MCP-1 Induce Migration of Human Umbilical Cord Blood Cells in Models of Stroke. Current neurovascular research. 5(2): 118-24, 2008.
  • Henning, RJ.Shariff, M.Eadula, U.Alvarado, F.Vasko, M.Sanberg, PR.Sanberg, CD.Delostia, V. Human cord blood mononuclear cells decrease cytokines and inflammatory cells in acute myocardial infarction. Stem cells and development. 17(6): 1207-19, 2008.
  • Bachstetter, AD.Pabon, MM.Cole, MJ.Hudson, CE.Sanberg, PR.Willing, AE.Bickford, PC.Gemma, C. Peripheral injection of human umbilical cord blood stimulates neurogenesis in the aged rat brain. BMC neuroscience. 9(): 22, 2008.
  • Nikolic, WV.Hou, H.Town, T.Zhu, Y.Giunta, B.Sanberg, CD.Zeng, J.Luo, D.Ehrhart, J.Mori, T.Sanberg, PR.Tan, J. Peripherally administered human umbilical cord blood cells reduce parenchymal and vascular beta-amyloid deposits in Alzheimer mice. Stem cells and development. 17(3): 423-39, 2008.
  • Yasuhara, T.Hara, K.Maki, M.Masuda, T.Sanberg, CD.Sanberg, PR.Bickford, PC.Borlongan, CV. Dietary supplementation exerts neuroprotective effects in ischemic stroke model. Rejuvenation research. 11(1): 201-14, 2008.
  • Yu, S.Kaneko, Y.Bae, E.Stahl, CE.Wang, Y.van Loveren, H.Sanberg, PR.Borlongan, CV. Severity of controlled cortical impact traumatic brain injury in rats and mice dictates degree of behavioral deficits. Brain research. 1287(): 157-63, 2009.
  • Saleh, IA.Zesiewicz, T.Xie, Y.Sullivan, KL.Miller, AM.Kuzmin-Nichols, N.Sanberg, PR.Garbuzova-Davis, S. Evaluation of humoral immune response in adaptive immunity in ALS patients during disease progression. Journal of neuroimmunology. 215(1-2): 96-101, 2009.
  • Shytle, RD.Bickford, PC.Rezai-zadeh, K.Hou, L.Zeng, J.Tan, J.Sanberg, PR.Sanberg, CD.Roschek, B.Fink, RC.Alberte, RS. Optimized turmeric extracts have potent anti-amyloidogenic effects. Current Alzheimer research. 6(6): 564-71, 2009.
  • Eve, DJ.Musso, J.Park, DH.Oliveira, C.Pollock, K.Hope, A.Baradez, MO.Sinden, JD.Sanberg, PR. Methodological study investigating long term laser Doppler measured cerebral blood flow changes in a permanently occluded rat stroke model. Journal of neuroscience methods. 180(1): 52-6, 2009.
  • Gografe, SI.Sanberg, PR.Chamizo, W.Monforte, H.Garbuzova-Davis, S. Novel pathologic findings associated with urinary retention in a mouse model of mucopolysaccharidosis type IIIB. Comparative medicine. 59(2): 139-46, 2009.
  • Garbuzova-Davis, S.Klasko, SK.Sanberg, PR. Intravenous administration of human umbilical cord blood cells in an animal model of MPS III B. The Journal of comparative neurology. 515(1): 93-101, 2009.
  • Park, DH.Eve, DJ.Sanberg, PR.Musso, J.Bachstetter, AD.Wolfson, A.Schlunk, A.Baradez, MO.Sinden, JD.Gemma, C. Increased neuronal proliferation in the dentate gyrus of aged rats following neural stem cell implantation. Stem cells and development. 19(2): 175-80, 2010.
  • Borlongan, CV.Kaneko, Y.Maki, M.Yu, SJ.Ali, M.Allickson, JG.Sanberg, CD.Kuzmin-Nichols, N.Sanberg, PR. Menstrual blood cells display stem cell-like phenotypic markers and exert neuroprotection following transplantation in experimental stroke. Stem cells and development. 19(4): 439-52, 2010.
  • Bachstetter, AD.Jernberg, J.Schlunk, A.Vila, JL.Hudson, C.Cole, MJ.Shytle, RD.Tan, J.Sanberg, PR.Sanberg, CD.Borlongan, C.Kaneko, Y.Tajiri, N.Gemma, C.Bickford, PC. Spirulina promotes stem cell genesis and protects against LPS induced declines in neural stem cell proliferation. PloS one. 5(5): e10496, 2010.
  • Jiang, L.Womble, T.Saporta, S.Chen, N.Sanberg, CD.Sanberg, PR.Willing, AE. Human umbilical cord blood cells decrease microglial survival in vitro. Stem cells and development. 19(2): 221-8, 2010.
  • Garbuzova-Davis, S.Woods, RL.Louis, MK.Zesiewicz, TA.Kuzmin-Nichols, N.Sullivan, KL.Miller, AM.Hernandez-Ontiveros, DG.Sanberg, PR. Reduction of circulating endothelial cells in peripheral blood of ALS patients. PloS one. 5(5): e10614, 2010.

    • Grants
  • BATTLEFIELD-RELATED INJURY TRANSLATIONAL RESEARCH, POST-TRAUMATIC DISEASE AND DISABILITY-VETERANS REINTEGRATION STRATEGY ($743,471.00, 09/20/2011-09/19/2013)
  • BATTLEFIELD-RELATED INJURY TRANSLATIONAL RESEARCH, POST-TRAUMATIC DISEASE AND DISABILITY-VETERANS REINTEGRATION STRATEGY ($829,526.00, 09/20/2011-09/19/2013)
  • TREATING SAN FILLIPO WITH UMBILICAL CORD BLOOD STEM CELLS ($50,000.00, 07/01/2001-06/30/2012)
  • TREATING SAN FILLIPO WITH UMBILICAL CORD BLOOD STEM CELLS ($40,000.00, 07/01/2001-06/30/2011)
  • AMERICAN SOCIETY FOR NEURAL THERAPY AND REPAIR ($18,000.00, 04/01/2010-03/31/2011)
  • TARGACEPT ($882,939.00, 07/01/2009-06/30/2010)
  • TREATING SAN FILLIPO WITH UMBILICAL CORD BLOOD STEM CELLS ($50,000.00, 07/01/2001-06/30/2010)
  • VA CONTRACT FOR SERVICES ($50,000.00, 09/29/2008-09/28/2009)
  • TREATING SAN FILLIPO WITH UMBILICAL CORD BLOOD STEM CELLS ($50,000.00, 07/01/2001-06/30/2008)
  • TREATING SAN FILLIPO WITH UMBILICAL CORD BLOOD STEM CELLS ($85,000.00, 07/01/2001-06/30/2008)
  • THE ANGIOGENIC AND REPARATIVE PROPERTIES OF A RENEURON STEM CELL LINE IN THE TREATMENT OF STROKE ($289,726.00, 01/01/2007-12/31/2007)
  • TREATING SAN FILLIPO WITH UMBILICAL CORD BLOOD STEM CELLS ($90,000.00, 07/01/2001-06/30/2006)
  • TREATING SAN FILLIPO WITH UMBILICAL CORD BLOOD STEM CELLS ($75,000.00, 07/01/2001-06/30/2005)
  • BEHAVIORAL AND NEUROPHARMACOLOGICAL PROFILES OF NOVEL NICOTINE ANTAGONIST FOR NEUROPSYCHIATRIC DISORDERS ($180,000.00, 10/14/2000-10/13/2004)
  • TREATING SAN FILLIPO WITH UMBILICAL CORD BLOOD STEM CELLS ($140,000.00, 07/01/2001-06/30/2004)
  • TREATING SAN FILLIPO WITH UMBILICAL CORD BLOOD STEM CELLS ($96,142.00, 07/01/2001-06/30/2004)
  • GRADUATE TRAINING FOR NURSES IN 3 SPECIALITY AREAS AND TRAINING FOR PHD CANDIDATES IN NEUROSCIENCES ($500,000.00, 06/16/2003-12/31/2003)
  • BEHAVIORAL AND NEUROPHARMACOLOGICAL PROFILES OF NOVEL NICOTINE ANTAGONIST FOR NEUROPSYCHIATRIC DISORDERS ($180,000.00, 10/14/2000-10/13/2003)
  • TREATING SAN FILLIPO WITH UMBILICAL CORD BLOOD STEM CELLS ($95,585.00, 07/01/2001-08/31/2002)


    • Lectures
  • "Early Drug Discovery to the " Georgetown University Patent Awards Ceremony, Announcing NAI. DC, United States - 2011.
  • "Umbilical Cord Blood and Stem Cells for Brain Repair" South Texas Blood & Tissue Center. TX, United States - 2010.
  • "Early Drug Discovery to the Marketplace: One Inventors Story" University of Cincinatti National Academy of Inventors Inaugural Celebration. OH, United States - 2010.
  • "Stem Cells in Pre-Clinical Studies in Regenerative Medicine" 8th Annual International Umbilical Cord Blood Transplantation Symposium. CA, United States - 2010.
  • "Toward Development of Novel Cell " 9th Annual Cell-Based Therapies & Tissue Engineeringnce. OH, United States - 2010.
  • "Novel Cell Therapies for Brain Repair" International Association of Neurorestoratology III Annual Conference. Republic of China - 2010.
  • "Umbilical Cord Blood, Monocytes and Nature's First Stem Cell" The 3rd Pan Pacific Symposium on Stem Cells Research 2010. Republic of China - 2010.
  • "Umbilical Cord Blood and Stem Cells for Brain Repair" Center for Brain Health Distinguished Lecture Series. TX, United States - 2010.
  • "The Impact of Regulatory Hurdles on Cell Therapy Clinical Trials" 2009 Advanced Technologies and Regenerative Medcine, LLC Cell Therapy Scientific . CT, United States - 2009.
  • "Novel Cell Therapies in Neuroscience: A Personal Perspective" Korea University Medical Center. South Korea - 2009.
  • "Toward Development of Novel Cell Therapies for Brain Repair" 49th Annual Meeting of the Korean Neurosurgical Society. South Korea - 2009.
  • "The Emerging Field of Cell and Tissue Transplantation: From Heart to Brain" Satellite Symposium, 7th World Congress on Alternatives & Animanl Use in the Life Sciences . Italy - 2009.
  • "The Emerging Field of Cell Transplantation and Tissue Engineering in Transplantation" American Transplant Congress. MA, United States - 2009.
  • "Umbilical Cord Blood and Menstrual Blood-Derived Stem Cells for Brain Repair " 2nd Pan Pacific Symposium on Stem Cells Research 2009. Republic of China - 2009.
  • "Novel Stem Cell Therapy for Brain Injury Repair" Western NC Chapter of the Society for Neuroscience. NC, United States - 2008.
  • "Cord Blood Cell Therapy for Brain and Heart Repair" Opening Ceremonies and Symposium. Thailand - 2008.
  • "Novel Stem Cell Therapy for Brain Injury Repair" 1st Pan Pacific Symposium on Stem Cells Research 2008. Republic of China - 2008.

    • Profile last modified on 02/08/2011